Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2013 1
2014 5
2015 7
2016 4
2017 6
2018 9
2019 11
2020 5
2021 5
2022 7
2023 9
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Results by year

Filters applied: . Clear all
Page 1
Current Landscape of Genomic Biomarkers in Clear Cell Renal Cell Carcinoma.
Cotta BH, Choueiri TK, Cieslik M, Ghatalia P, Mehra R, Morgan TM, Palapattu GS, Shuch B, Vaishampayan U, Van Allen E, Ari Hakimi A, Salami SS. Cotta BH, et al. Among authors: ghatalia p. Eur Urol. 2023 Aug;84(2):166-175. doi: 10.1016/j.eururo.2023.04.003. Epub 2023 Apr 19. Eur Urol. 2023. PMID: 37085424 Review.
Systemic therapy in bladder preservation.
Girardi DM, Ghatalia P, Singh P, Iyer G, Sridhar SS, Apolo AB. Girardi DM, et al. Among authors: ghatalia p. Urol Oncol. 2023 Jan;41(1):39-47. doi: 10.1016/j.urolonc.2020.10.006. Epub 2020 Nov 19. Urol Oncol. 2023. PMID: 33223367 Free article. Review.
Muscle invasive bladder cancer: where is the field headed?
Ghatalia P, Kaur J, Sonpavde G. Ghatalia P, et al. Expert Opin Biol Ther. 2023 Jul-Dec;23(9):913-927. doi: 10.1080/14712598.2023.2238607. Epub 2023 Jul 21. Expert Opin Biol Ther. 2023. PMID: 37477127 Review.
A Phase II Trial of Guadecitabine plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy.
Jang HJ, Hostetter G, Macfarlane AW, Madaj Z, Ross EA, Hinoue T, Kulchycki JR, Burgos RS, Tafseer M, Alpaugh RK, Schwebel CL, Kokate R, Geynisman DM, Zibelman MR, Ghatalia P, Nichols PW, Chung W, Madzo J, Hahn NM, Quinn DI, Issa JJ, Topper MJ, Baylin SB, Shen H, Campbell KS, Jones PA, Plimack ER. Jang HJ, et al. Among authors: ghatalia p. Clin Cancer Res. 2023 Jun 1;29(11):2052-2065. doi: 10.1158/1078-0432.CCR-22-3642. Clin Cancer Res. 2023. PMID: 36928921 Free PMC article. Clinical Trial.
Role of perioperative immunotherapy in localized renal cell carcinoma.
Kaur J, Patil G, Geynisman DM, Ghatalia P. Kaur J, et al. Among authors: ghatalia p. Ther Adv Med Oncol. 2023 Jul 29;15:17588359231181497. doi: 10.1177/17588359231181497. eCollection 2023. Ther Adv Med Oncol. 2023. PMID: 37529159 Free PMC article. Review.
Role of immunotherapy in localized muscle invasive urothelial cancer.
Kaur J, Choi W, Geynisman DM, Plimack ER, Ghatalia P. Kaur J, et al. Among authors: ghatalia p. Ther Adv Med Oncol. 2021 Sep 22;13:17588359211045858. doi: 10.1177/17588359211045858. eCollection 2021. Ther Adv Med Oncol. 2021. PMID: 34567274 Free PMC article. Review.
56 results